163 related articles for article (PubMed ID: 12077538)
1. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
Lambert J; Trompke C
Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
3. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
5. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
8. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
9. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis.
Dua I; Aggarwal K; Jain VK
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032
[TBL] [Abstract][Full Text] [Related]
11. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
Tzaneva S; Hönigsmann H; Tanew A; Seeber A
Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
[TBL] [Abstract][Full Text] [Related]
12. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
13. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
14. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis.
Aggarwal P; Aggarwal K; Jain VK
J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
16. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
Langner A; Ashton P; Van De Kerkhof PC; Verjans H
Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
[TBL] [Abstract][Full Text] [Related]
17. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
19. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study.
Helfrich YR; Kang S; Hamilton TA; Voorhees JJ
Br J Dermatol; 2007 Aug; 157(2):369-74. PubMed ID: 17596167
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
